Hospital
Mercy Hospital Joplin
Mercy Hospital Joplin was paid $46.70M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is Y7506, — 19% of everything it billed.
33Billing provider infoMERCY HOSPITAL JOPLIN
JOPLIN, MO 64804
JOPLIN, MO 64804
33aNPI1700112745assigned 10/27/2009
33bProvider typePsychiatric Hospital Unit
28Total paid$46.70M
24GClaims301,246
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Missouri
Rank by total paid#3 of 9
Median peer was paid$8.82M
This provider vs. median5.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,259 | $15.61M | |
| 2019 | 50,129 | $13.25M | |
| 2020 | 42,654 | $5.40M | |
| 2021 | 37,014 | $1.64M | |
| 2022 | 39,178 | $3.34M | |
| 2023 | 51,092 | $4.38M | |
| 2024incomplete | 34,920 | $3.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Y7506 | 19% | 29,825 | 23,874 | $8.89M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 16,406 | 15,757 | $5.33M |
| X4011 | State-specific procedure code | 8.2% | 10,945 | 10,308 | $3.84M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.9% | 40,226 | 36,367 | $3.69M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.7% | 14,985 | 14,656 | $3.58M |
| 80053 | Comprehensive metabolic panel | 6.8% | 44,958 | 38,715 | $3.17M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.9% | 8,970 | 8,724 | $2.76M |
| X4006 | 4.1% | 2,808 | 1,790 | $1.91M | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.8% | 13,919 | 13,048 | $1.31M |
| 81001 | 2.6% | 7,910 | 7,606 | $1.23M | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.2% | 3,780 | 3,626 | $1.03M |
| 71045 | Radiologic examination, chest; single view | 1.6% | 9,015 | 8,588 | $763K |
135 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.6% | 6,000 | $743K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,626 | $643K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 5,326 | $565K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.2% | 4,901 | $563K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.1% | 1,419 | $513K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.1% | 1,303 | $494K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,488 | $395K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,067 | $378K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,766 | $323K |
| 88312 | <1% | 3,442 | $321K | |
| 81002 | <1% | 1,664 | $261K | |
| 83690 | <1% | 1,664 | $224K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,253 | $191K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,671 | $178K |
| 87081 | <1% | 1,085 | $174K | |
| X4003 | <1% | 1,184 | $173K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 349 | $166K |
| 80306 | <1% | 2,011 | $158K | |
| 43249 | <1% | 401 | $146K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,548 | $146K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,111 | $133K |
| G0378 | Hospital observation service, per hour | <1% | 257 | $128K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 487 | $117K |
| 84484 | <1% | 2,907 | $117K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 733 | $114K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,773 | $103K |
| 85027 | <1% | 228 | $98K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,364 | $98K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 860 | $88K |
| 85610 | <1% | 619 | $86K | |
| 81025 | <1% | 674 | $84K | |
| 86140 | <1% | 1,514 | $73K | |
| 84145 | <1% | 495 | $65K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,632 | $64K |
| J3490 | Unclassified drugs | <1% | 7,997 | $64K |
| 59025 | Fetal non-stress test | <1% | 451 | $63K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 765 | $59K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 242 | $54K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 15 | $50K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 847 | $49K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 847 | $49K |
| 80081 | <1% | 653 | $49K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 325 | $48K |
| 87807 | <1% | 75 | $47K | |
| 74022 | <1% | 66 | $39K | |
| 81003 | <1% | 1,708 | $38K | |
| 87653 | <1% | 653 | $38K | |
| 82962 | <1% | 372 | $32K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 102 | $28K |
| 86803 | <1% | 520 | $24K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 765 | $19K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 131 | $17K |
| 83605 | <1% | 80 | $16K | |
| 85652 | <1% | 708 | $15K | |
| 93880 | <1% | 227 | $15K | |
| 80143 | <1% | 707 | $12K | |
| 80179 | <1% | 707 | $12K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 16 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 12 | $11K |
| 85018 | <1% | 57 | $11K | |
| 85014 | <1% | 56 | $11K | |
| Y7507 | <1% | 104 | $11K | |
| 82077 | <1% | 755 | $11K | |
| 87428 | <1% | 342 | $11K | |
| 96367 | <1% | 283 | $11K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 112 | $11K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 26 | $11K |
| 87486 | <1% | 26 | $11K | |
| 87581 | <1% | 26 | $11K | |
| 84702 | <1% | 80 | $8K | |
| 91010 | <1% | 43 | $8K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 112 | $8K |
| 82950 | <1% | 437 | $7K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 116 | $6K |
| 82947 | <1% | 392 | $6K | |
| 77336 | <1% | 162 | $5K | |
| 83735 | <1% | 1,253 | $5K | |
| 83880 | <1% | 172 | $5K | |
| 87070 | <1% | 407 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 16 | $4K |
| 94761 | <1% | 27 | $3K | |
| 80061 | Lipid panel | <1% | 269 | $3K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 27 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 88 | $3K |
| 87400 | <1% | 89 | $2K | |
| 96417 | <1% | 38 | $2K | |
| 94729 | <1% | 26 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 183 | $2K |
| 85730 | <1% | 71 | $2K | |
| 74018 | <1% | 52 | $2K | |
| 87660 | <1% | 48 | $2K | |
| 87480 | <1% | 44 | $2K | |
| 87510 | <1% | 30 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,845 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 27 | $1K |
| 94618 | <1% | 26 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $1K |
| 88304 | <1% | 25 | $930.19 | |
| 80076 | <1% | 42 | $840.12 | |
| 99460 | <1% | 12 | $793.44 | |
| 86705 | <1% | 12 | $752.57 | |
| 86317 | <1% | 12 | $746.95 | |
| 87340 | <1% | 12 | $735.91 | |
| 84439 | <1% | 18 | $712.04 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 268 | $669.14 |
| 86900 | <1% | 16 | $532.10 | |
| 86850 | <1% | 16 | $521.46 | |
| 93017 | <1% | 12 | $506.02 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 12 | $500.25 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 14 | $443.07 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,216 | $407.74 |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 58 | $369.08 |
| 87147 | <1% | 13 | $342.99 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 67 | $284.72 |
| 87641 | <1% | 12 | $268.43 | |
| 86901 | <1% | 16 | $262.20 | |
| 87420 | <1% | 19 | $202.84 | |
| 82043 | <1% | 13 | $195.52 | |
| 82570 | <1% | 13 | $191.67 | |
| 82565 | <1% | 12 | $185.85 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 114 | $168.71 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 19 | $147.69 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 55 | $63.35 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 129 | $55.61 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 62 | $51.00 |
| 0641T | <1% | 40 | $50.41 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 71 | $50.14 |
| 80069 | <1% | 12 | $45.42 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 18 | $18.97 |
| 0640T | <1% | 14 | $17.98 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 14 | $4.86 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 88 | $0.00 |
| A9270 | Non-covered item or service | 0% | 236 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFAST, DOUGLAS (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Mercy Hospital Joplin | Neosho, MO | $793K |
| Mercy Specialty Hospital Southeast Kansas | Galena, KS | $43K |
| Mercy Hospital Pittsburg INC | Pittsburg, KS | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.